The distance from price to cash
MAIRE is allocating $220 million to LNG technologies through Nextchem. My starting point is the acquired licensing business's estimated EBITDA of at least $25 million for 2027. Dividing the consideration by that baseline gives approximately 8.8 times. That is an arithmetic check consistent with management's description of a high-single-digit multiple. The denominator, however, is an operating forecast for a future year rather than a completed year's cash return. That distinction is the starting point for assessing the transaction's economic burden.[1]
The purchase consideration is also financed through dedicated credit facilities. Licensing EBITDA and the amount left for shareholders after interest and other cash outflows are different quantities. The announcement says BPER Banca has fully underwritten the financing; that describes how funding has been arranged. Without a borrowing rate, the cash remaining for shareholders cannot be calculated. Reading 8.8 times as a payback period would therefore confuse an operating earnings measure with cash available after financing and other obligations.[1]
From technology to the next contract
The acquired assets extend beyond patents. Alongside more than 90 patents, the package includes a 12-person specialist team, licensing processes and a 10-year cold-box supply relationship with Chart. The economic proposition is earlier involvement in project design and access to subsequent engineering work for MAIRE. My interpretation of the transaction structure is that a licence can create a route to additional work. A plausible alternative is that customers license the process but distribute subsequent engineering and equipment contracts among other suppliers.[1]
The capacity figures also describe three distinct stages. Operating references represent approximately 14 million tonnes of annual capacity. Projects under construction total 57 million tonnes, including 30 million tonnes of residual backlog. Projects that have selected the technology before a final investment decision account for 90 million tonnes. The last category describes commercial potential. Without a disclosed conversion from a tonne of capacity into a dollar of licensing revenue, adding those figures together does not produce a revenue forecast.[1]
When the fee is earned
The sensitive assumption is therefore the speed at which technology selections become fee-generating work. Licensing revenue earned ahead of later project delivery is one mechanism that could make early design involvement valuable. Alternatively, delayed investment decisions can leave the same opportunity pipeline waiting. Both possibilities fit the disclosed project stages; capacity alone does not resolve timing. In assessing the multiple, I prefer the stated licensing baseline to a denominator enlarged in advance by possible equipment revenue or synergies.[1]
MAIRE describes equipment contributions and group revenue synergies as potential additions. Their specific channel is the combination of technology selection, engineering and project delivery within one group. The $220 million consideration is cash at closing, while those additional revenues remain expectations. In my assessment, that timing difference concentrates the burden borne by shareholders. The economically decisive amount is licensing earnings converted into cash after financing, rather than the patent count. Today's announcement supplies an opening assumption for that conversion, rather than a realised return.[1]